Page last updated: 2024-09-04

alpinetin and Disease Exacerbation

alpinetin has been researched along with Disease Exacerbation in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lu, JB; Wu, L; Yang, W; Zhang, SN	1

Other Studies

1 other study(ies) available for alpinetin and Disease Exacerbation

Article	Year
Alpinetin inhibits lung cancer progression and elevates sensitization drug-resistant lung cancer cells to cis-diammined dichloridoplatium. Drug design, development and therapy, 2015, Volume: 9 Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Cisplatin; Disease Progression; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Flavanones; Humans; Lung Neoplasms; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; Structure-Activity Relationship; Tumor Cells, Cultured	2015

Article

Year

Alpinetin inhibits lung cancer progression and elevates sensitization drug-resistant lung cancer cells to cis-diammined dichloridoplatium.

Drug design, development and therapy, 2015, Volume: 9

Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Cisplatin; Disease Progression; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Flavanones; Humans; Lung Neoplasms; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; Structure-Activity Relationship; Tumor Cells, Cultured

2015